Trial Profile
A study of Tolimidone for Nonalcoholic steatohepatitis (NASH)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2018
Price :
$35
*
At a glance
- Drugs Tolimidone (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 25 Oct 2018 New trial record
- 16 Oct 2018 According to a Melior Pharmaceuticals, Inc. media release, the company expects to initiate the trial in early 2019.